News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Toshio Shimizu

Articles by Toshio Shimizu

8 Datopotamab Deruxtecan (Dato-DXd) in Advanced Triple- Negative Breast Cancer (TNBC): Updated Results From the Phase 1 TROPION-PanTumor01 Study

ByAditya Bardia, MD, MPH, FASCO,Ian E. Krop,Funda Meric-Bernstam, MD,Anthony W. Tolcher,Toru Mukohara,Aaron Lisberg,Toshio Shimizu,Erika P. Hamilton, MD,Alexander Spira, MD, PhD, FACP,Takahiro Kogawa

April 28th 2023

Latest Updated Articles

Trending on CancerNetwork

Ziftomenib Plus 7+3 Yields High Response Rates in Newly Diagnosed AML

Pirtobrutinib Plus Venetoclax/Rituximab Improves PFS in Pretreated CLL

Arlo-Cel Produces Deep Responses in Pretreated R/R Multiple Myeloma

Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL

FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM